mibefradil has been researched along with Medulloblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azimi, I; Dutta, T; Feng, Z; Gueven, N; Maklad, A; Sedeeq, M; Wilson, R | 1 |
| Ernest, NJ; Logsdon, NJ; McFerrin, MB; Sontheimer, H; Spiller, SE | 1 |
2 other study(ies) available for mibefradil and Medulloblastoma
| Article | Year |
|---|---|
T-Type Calcium Channel Inhibitors Induce Apoptosis in Medulloblastoma Cells Associated with Altered Metabolic Activity.
Topics: Apoptosis; Calcium; Calcium Channel Blockers; Calcium Channels, T-Type; Cerebellar Neoplasms; Child; Humans; Medulloblastoma; Mibefradil; Neoplasm Recurrence, Local; Vincristine | 2022 |
Biophysical properties of human medulloblastoma cells.
Topics: Action Potentials; Blotting, Western; Cells; Cells, Cultured; Electrophysiology; Humans; Medulloblastoma; Membrane Potentials; Mibefradil; Nerve Tissue Proteins; Peptides; Potassium Channels, Calcium-Activated; Potassium Channels, Tandem Pore Domain; Ruthenium Red | 2010 |